Prevention of neointimal hyperplasia after coronary artery bypass graft via local delivery of sirolimus and rosuvastatin: network pharmacology and in vivo validation.

J Transl Med · 2024 · PMC10874014 · PMID 38365767

Europe PMC DOI

hedged sentence

0.0594

closest p · 1.2× alpha

0.0594

boldest claim

The sentences

a decreasing trendp = 0.0594so close (0.05 < p ≤ 0.1)

Moreover, p-mTOR expression showed a decreasing trend in the SIR + RSV group (3.83-fold decrease; p = 0.0594).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.